annual EBIT:
-$158.83M-$44.48M(-38.89%)Summary
- As of today (July 6, 2025), EWTX annual earnings before interest & taxes is -$158.83 million, with the most recent change of -$44.48 million (-38.89%) on December 31, 2024.
- During the last 3 years, EWTX annual EBIT has fallen by -$115.62 million (-267.54%).
- EWTX annual EBIT is now -1500.48% below its all-time high of -$9.92 million, reached on December 31, 2019.
Performance
EWTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$45.96M-$419.00K(-0.92%)Summary
- As of today (July 6, 2025), EWTX quarterly earnings before interest & taxes is -$45.96 million, with the most recent change of -$419.00 thousand (-0.92%) on March 31, 2025.
- Over the past year, EWTX quarterly EBIT has dropped by -$11.21 million (-32.24%).
- EWTX quarterly EBIT is now -1314.99% below its all-time high of -$3.25 million, reached on March 31, 2020.
Performance
EWTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$170.04M-$11.21M(-7.06%)Summary
- As of today (July 6, 2025), EWTX TTM earnings before interest & taxes is -$170.04 million, with the most recent change of -$11.21 million (-7.06%) on March 31, 2025.
- Over the past year, EWTX TTM EBIT has dropped by -$46.63 million (-37.79%).
- EWTX TTM EBIT is now -5135.16% below its all-time high of -$3.25 million, reached on March 31, 2020.
Performance
EWTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EWTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.9% | -32.2% | -37.8% |
| 3 y3 years | -267.5% | -210.0% | -232.2% |
| 5 y5 years | -1500.5% | -1315.0% | -2260.0% |
EWTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -267.5% | at low | -178.7% | at low | -197.2% | at low |
| 5 y | 5-year | -1500.5% | at low | -1161.6% | at low | -2260.0% | at low |
| alltime | all time | -1500.5% | at low | -1315.0% | at low | -5135.2% | at low |
EWTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$45.96M(+0.9%) | -$170.04M(+7.1%) |
| Dec 2024 | -$158.83M(+38.9%) | -$45.54M(+12.6%) | -$158.83M(+7.9%) |
| Sep 2024 | - | -$40.43M(+6.1%) | -$147.15M(+8.1%) |
| Jun 2024 | - | -$38.11M(+9.7%) | -$136.17M(+10.3%) |
| Mar 2024 | - | -$34.75M(+2.6%) | -$123.41M(+7.9%) |
| Dec 2023 | -$114.36M(+59.6%) | -$33.86M(+15.0%) | -$114.36M(+11.5%) |
| Sep 2023 | - | -$29.45M(+16.2%) | -$102.57M(+12.2%) |
| Jun 2023 | - | -$25.34M(-1.4%) | -$91.38M(+10.7%) |
| Mar 2023 | - | -$25.70M(+16.4%) | -$82.54M(+15.2%) |
| Dec 2022 | -$71.66M | -$22.08M(+20.9%) | -$71.66M(+14.8%) |
| Sep 2022 | - | -$18.26M(+10.7%) | -$62.40M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$16.49M(+11.2%) | -$57.22M(+11.8%) |
| Mar 2022 | - | -$14.83M(+15.6%) | -$51.18M(+18.4%) |
| Dec 2021 | -$43.22M(+151.4%) | -$12.82M(-1.9%) | -$43.22M(+17.6%) |
| Sep 2021 | - | -$13.08M(+25.0%) | -$36.74M(+34.5%) |
| Jun 2021 | - | -$10.46M(+52.5%) | -$27.30M(+31.3%) |
| Mar 2021 | - | -$6.86M(+8.1%) | -$20.80M(+21.0%) |
| Dec 2020 | -$17.19M(+73.2%) | -$6.34M(+74.1%) | -$17.19M(+58.5%) |
| Sep 2020 | - | -$3.64M(-7.9%) | -$10.85M(+50.6%) |
| Jun 2020 | - | -$3.96M(+21.8%) | -$7.21M(+121.8%) |
| Mar 2020 | - | -$3.25M | -$3.25M |
| Dec 2019 | -$9.92M | - | - |
FAQ
- What is Edgewise Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual EBIT year-on-year change?
- What is Edgewise Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly EBIT year-on-year change?
- What is Edgewise Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM EBIT year-on-year change?
What is Edgewise Therapeutics annual earnings before interest & taxes?
The current annual EBIT of EWTX is -$158.83M
What is the all time high annual EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual earnings before interest & taxes is -$9.92M
What is Edgewise Therapeutics annual EBIT year-on-year change?
Over the past year, EWTX annual earnings before interest & taxes has changed by -$44.48M (-38.89%)
What is Edgewise Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of EWTX is -$45.96M
What is the all time high quarterly EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly earnings before interest & taxes is -$3.25M
What is Edgewise Therapeutics quarterly EBIT year-on-year change?
Over the past year, EWTX quarterly earnings before interest & taxes has changed by -$11.21M (-32.24%)
What is Edgewise Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of EWTX is -$170.04M
What is the all time high TTM EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM earnings before interest & taxes is -$3.25M
What is Edgewise Therapeutics TTM EBIT year-on-year change?
Over the past year, EWTX TTM earnings before interest & taxes has changed by -$46.63M (-37.79%)